Examining Changes in Personality Following Shamanic Ceremonial Use of Ayahuasca Brandon Weiss*, Joshua D
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Ayahuasca: Spiritual Pharmacology & Drug Interactions
Ayahuasca: Spiritual Pharmacology & Drug Interactions BENJAMIN MALCOLM, PHARMD, MPH [email protected] MARCH 28 TH 2017 AWARE PROJECT Can Science be Spiritual? “Science is not only compatible with spirituality; it is a profound source of spirituality. When we recognize our place in an immensity of light years and in the passage of ages, when we grasp the intricacy, beauty and subtlety of life, then that soaring feeling, that sense of elation and humility combined, is surely spiritual. The notion that science and spirituality are somehow mutually exclusive does a disservice to both.” – Carl Sagan Disclosures & Disclaimers No conflicts of interest to disclose – I don’t get paid by pharma and have no potential to profit directly from ayahuasca This presentation is for information purposes only, none of the information presented should be used in replacement of medical advice or be considered medical advice This presentation is not an endorsement of illicit activity Presentation Outline & Objectives Describe what is known regarding ayahuasca’s pharmacology Outline adverse food and drug combinations with ayahuasca as well as strategies for risk management Provide an overview of spiritual pharmacology and current clinical data supporting potential of ayahuasca for treatment of mental illness Pharmacology Terms Drug ◦ Term used synonymously with substance or medicine in this presentation and in pharmacology ◦ No offense intended if I call your medicine or madre a drug! Bioavailability ◦ The amount of a drug that enters the body and is able to have an active effect ◦ Route specific: bioavailability is different between oral, intranasal, inhalation (smoked), and injected routes of administration (IV, IM, SC) Half-life (T ½) ◦ The amount of time it takes the body to metabolize/eliminate 50% of a drug ◦ E.g. -
The Varieties of Self-Transcendent Experience David Bryce Yaden, Jonathan Haidt, Ralph W
Review of General Psychology The Varieties of Self-Transcendent Experience David Bryce Yaden, Jonathan Haidt, Ralph W. Hood, Jr., David R. Vago, and Andrew B. Newberg Online First Publication, May 1, 2017. http://dx.doi.org/10.1037/gpr0000102 CITATION Yaden, D. B., Haidt, J., Hood, R. W., Jr., Vago, D. R., & Newberg, A. B. (2017, May 1). The Varieties of Self-Transcendent Experience. Review of General Psychology. Advance online publication. http://dx.doi.org/10.1037/gpr0000102 Review of General Psychology © 2017 American Psychological Association 2017, Vol. 0, No. 999, 000 1089-2680/17/$12.00 http://dx.doi.org/10.1037/gpr0000102 The Varieties of Self-Transcendent Experience David Bryce Yaden Jonathan Haidt University of Pennsylvania New York University Ralph W. Hood Jr. David R. Vago University of Tennessee at Chattanooga Harvard Medical School Andrew B. Newberg Thomas Jefferson University Various forms of self-loss have been described as aspects of mental illness (e.g., depersonalization disorder), but might self-loss also be related to mental health? In this integrative review and proposed organizational framework, we focus on self-transcendent experiences (STEs)—transient mental states marked by decreased self-salience and increased feelings of connectedness. We first identify common psychological constructs that contain a self-transcendent aspect, including mindfulness, flow, peak experiences, mystical-type experiences, and certain positive emotions (e.g., love, awe). We then propose psychological and neurobiological mechanisms that may mediate the effects of STEs based on a review of the extant literature from social psychology, clinical psychology, and affective neuroscience. We conclude with future directions for further empirical research on these experiences. -
Developmental Structure of Personality and Interests: a Four-Wave, 8- Year Longitudinal Study
Journal of Personality and Social Psychology: Personality Processes and Individual Differences © 2019 American Psychological Association 2020, Vol. 118, No. 5, 1044–1064 0022-3514/20/$12.00 http://dx.doi.org/10.1037/pspp0000228 PERSONALITY PROCESSES AND INDIVIDUAL DIFFERENCES Developmental Structure of Personality and Interests: A Four-Wave, 8- Year Longitudinal Study Kevin A. Hoff Q. Chelsea Song University of Illinois at Urbana-Champaign Purdue University Sif Einarsdóttir Daniel A. Briley and James Rounds University of Iceland University of Illinois at Urbana-Champaign Personality traits and vocational interests capture different aspects of human individuality that intersect in certain ways. In this longitudinal study, we examined developmental relations between the Big 5 traits and RIASEC vocational interests over 4 timepoints from late adolescence to young adulthood (age 16–24) in a sample of Icelandic youth (N ϭ 485) well-representative of the total student population. Results showed that interests and personality traits were similarly stable over time, but showed different patterns of mean-level change. There was evidence of personality maturation but a lack of cumulative changes in interest levels. For the most part, gender differences in developmental trends were minimal. In addition, latent growth curve analyses revealed broad and specific correlated changes between personality and interests. Changes in general factors of personality and interests were moderately related (r ϭ .32), but stronger correlated changes were found among specific personality–interest pairs that share situational content. Overall, results reveal how interests and personality are related across different types of continuity and change. While there was little correspondence between group-level changes, substantial correlated change occurred at the individual level. -
Cyberbullies on Campus, 37 U. Tol. L. Rev. 51 (2005)
UIC School of Law UIC Law Open Access Repository UIC Law Open Access Faculty Scholarship 2005 Cyberbullies on Campus, 37 U. Tol. L. Rev. 51 (2005) Darby Dickerson John Marshall Law School Follow this and additional works at: https://repository.law.uic.edu/facpubs Part of the Education Law Commons, Legal Education Commons, and the Legal Profession Commons Recommended Citation Darby Dickerson, Cyberbullies on Campus, 37 U. Tol. L. Rev. 51 (2005) https://repository.law.uic.edu/facpubs/643 This Article is brought to you for free and open access by UIC Law Open Access Repository. It has been accepted for inclusion in UIC Law Open Access Faculty Scholarship by an authorized administrator of UIC Law Open Access Repository. For more information, please contact [email protected]. CYBERBULLIES ON CAMPUS Darby Dickerson * I. INTRODUCTION A new challenge facing educators is how to deal with the high-tech incivility that has crept onto our campuses. Technology has changed the way students approach learning, and has spawned new forms of rudeness. Students play computer games, check e-mail, watch DVDs, and participate in chat rooms during class. They answer ringing cell phones and dare to carry on conversations mid-lesson. Dealing with these types of incivilities is difficult enough, but another, more sinister e-culprit-the cyberbully-has also arrived on law school campuses. Cyberbullies exploit technology to control and intimidate others on campus.' They use web sites, blogs, and IMs2 to malign professors and classmates.3 They craft e-mails that are offensive, boorish, and cruel. They blast professors and administrators for grades given and policies passed; and, more often than not, they mix in hateful attacks on our character, motivations, physical attributes, and intellectual abilities.4 They disrupt classes, cause tension on campus, and interfere with our educational mission. -
Preparation for a Workshop How to Prepare for Healing
Preparation for a Workshop How to Prepare for Healing with Ayahuasca The Temple of the Way of Light http://templeofthewayoflight.org/ How to Prepare for Healing with Ayahuasca 2 Why Preparation is Important Comprehensive preparation for working with ayahuasca and a resolute commitment to ongoing integration after your retreat are as important as the healing you will experience whilst at the Temple. It is critical that you commit at the deepest level possible to the advice contained in this document – before, during and after your retreat – in order to ensure your healing experience is positive, safe and sustained over the long term. M any people from the West who are new to ayahuasca come with a misconception of the way the medicine works. There is no “quick fix” when awakening to higher aspects of consciousness or alleviating long-term pain and suffering. We can never offer any guarantees regarding healing, but we do sincerely and wholeheartedly promise to always try our best. Indigenous traditions have worked with ayahuasca for thousands of years and have never viewed it as a quick fix or a recreational experience. However, ayahuasca and the healing traditions of the Amazon are often able to offer a significant intervention into chronic emotional/psycho-spiritual imbalances and, sometimes, physical health conditions. It is fundamentally a transformational pathway to integrate and release the causes of pain and suffering. Ayahuasca is a powerful cleansing and purifying medicine that can rid the body of physical impurities, the mind and body of emotional blockages and self-limiting fear-filled patterns that have accumulated over a lifetime, as well as retrieve fragmented aspects of one’s soul due to past traumatic events. -
Hallucinogens and Dissociative Drugs
Long-Term Effects of Hallucinogens See page 5. from the director: Research Report Series Hallucinogens and dissociative drugs — which have street names like acid, angel dust, and vitamin K — distort the way a user perceives time, motion, colors, sounds, and self. These drugs can disrupt a person’s ability to think and communicate rationally, or even to recognize reality, sometimes resulting in bizarre or dangerous behavior. Hallucinogens such as LSD, psilocybin, peyote, DMT, and ayahuasca cause HALLUCINOGENS AND emotions to swing wildly and real-world sensations to appear unreal, sometimes frightening. Dissociative drugs like PCP, DISSOCIATIVE DRUGS ketamine, dextromethorphan, and Salvia divinorum may make a user feel out of Including LSD, Psilocybin, Peyote, DMT, Ayahuasca, control and disconnected from their body PCP, Ketamine, Dextromethorphan, and Salvia and environment. In addition to their short-term effects What Are on perception and mood, hallucinogenic Hallucinogens and drugs are associated with psychotic- like episodes that can occur long after Dissociative Drugs? a person has taken the drug, and dissociative drugs can cause respiratory allucinogens are a class of drugs that cause hallucinations—profound distortions depression, heart rate abnormalities, and in a person’s perceptions of reality. Hallucinogens can be found in some plants and a withdrawal syndrome. The good news is mushrooms (or their extracts) or can be man-made, and they are commonly divided that use of hallucinogenic and dissociative Hinto two broad categories: classic hallucinogens (such as LSD) and dissociative drugs (such drugs among U.S. high school students, as PCP). When under the influence of either type of drug, people often report rapid, intense in general, has remained relatively low in emotional swings and seeing images, hearing sounds, and feeling sensations that seem real recent years. -
Neuroticism, Depression, and Anxiety Traits Exacerbate the State of Cognitive Impairment and Hippocampal Vulnerability to Alzheimer’S Disease
Alzheimer’s& Dementia: Diagnosis, Assessment & Disease Monitoring 7 (2017) 107-114 Special Section: Neuropsychiatric Contributions to Alzheimer’s Disease Neuroticism, depression, and anxiety traits exacerbate the state of cognitive impairment and hippocampal vulnerability to Alzheimer’s disease Valerie Zuffereya,b, Alessia Donatib, Julius Poppb, Reto Meulic,Jerome^ Rossierd, Richard Frackowiaka, Bogdan Draganskia,e, Armin von Guntenb, Ferath Kherifa,* aLaboratoire de Recherche en Neuroimagerie (LREN), Departement des neurosciences cliniques, Centre Hospitalier Universitaire Vaudois, Universitede Lausanne, Lausanne, Switzerland bService of Old Age Psychiatry, Department of Psychiatry, Centre Hospitalier Universitaire Vaudois, Prilly-Lausanne, Switzerland cDepartment of Diagnostic and Interventional Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland dFaculty of Social and Political Sciences, Institute of Psychology, University of Lausanne, Lausanne, Switzerland eMax Planck Institute for Human Cognitive and Brain Sciences, Leipzig, Germany Abstract Introduction: Certain personality traits are associated with higher risk of Alzheimer’s disease, similar to cognitive impairment. The identification of biological markers associated with personality in mild cognitive impairment could advance the early detection of Alzheimer’s disease. Methods: We used hierarchical multivariate linear models to quantify the interaction between per- sonality traits, state of cognitive impairment, and MRI biomarkers (gray matter brain volume, gray matter mean water diffusion) in the medial temporal lobe (MTL). Results: Over and above a main effect of cognitive state, the multivariate linear model showed sig- nificant interaction between cognitive state and personality traits predicting MTL abnormality. The interaction effect was mainly driven by neuroticism and its facets (anxiety, depression, and stress) and was associated with right-left asymmetry and an anterior to posterior gradient in the MTL. -
How Should Therapists Respond to Client Accounts of Out-Of-Body Experience? Alexander De Foe Monash University
International Journal of Transpersonal Studies Volume 31 | Issue 1 Article 10 1-1-2012 How Should Therapists Respond to Client Accounts of Out-of-Body Experience? Alexander De Foe Monash University Follow this and additional works at: https://digitalcommons.ciis.edu/ijts-transpersonalstudies Part of the Philosophy Commons, Psychology Commons, and the Religion Commons Recommended Citation De Foe, A. (2012). De Foe, A. (2012). How should therapists respond to client accounts of out-of-body experience? International Journal of Transpersonal Studies, 31(1), 75–82.. International Journal of Transpersonal Studies, 31 (1). http://dx.doi.org/10.24972/ ijts.2012.31.1.75 This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License. This Special Topic Article is brought to you for free and open access by the Journals and Newsletters at Digital Commons @ CIIS. It has been accepted for inclusion in International Journal of Transpersonal Studies by an authorized administrator of Digital Commons @ CIIS. For more information, please contact [email protected]. How Should Therapists Respond to Client Accounts of Out-of-Body Experience? Alexander De Foe Monash University Melbourne, Australia During an out-of-body experience (OBE) a person experiences their center of consciousness from a spatial location that is distinctly different to their physical body. Prior research has suggested that psychologists and psychotherapists may be reluctant to discuss the content of their clients OBE accounts due to a lack of understanding about the nature of these experiences. Yet, other research has highlighted the substantial value of discussing OBEs in the therapeutic process. -
From Sacred Plants to Psychotherapy
From Sacred Plants to Psychotherapy: The History and Re-Emergence of Psychedelics in Medicine By Dr. Ben Sessa ‘The rejection of any source of evidence is always treason to that ultimate rationalism which urges forward science and philosophy alike’ - Alfred North Whitehead Introduction: What exactly is it that fascinates people about the psychedelic drugs? And how can we best define them? 1. Most psychiatrists will define psychedelics as those drugs that cause an acute confusional state. They bring about profound alterations in consciousness and may induce perceptual distortions as part of an organic psychosis. 2. Another definition for these substances may come from the cross-cultural dimension. In this context psychedelic drugs may be recognised as ceremonial religious tools, used by some non-Western cultures in order to communicate with the spiritual world. 3. For many lay people the psychedelic drugs are little more than illegal and dangerous drugs of abuse – addictive compounds, not to be distinguished from cocaine and heroin, which are only understood to be destructive - the cause of an individual, if not society’s, destruction. 4. But two final definitions for psychedelic drugs – and those that I would like the reader to have considered by the end of this article – is that the class of drugs defined as psychedelic, can be: a) Useful and safe medical treatments. Tools that as adjuncts to psychotherapy can be used to alleviate the symptoms and course of many mental illnesses, and 1 b) Vital research tools with which to better our understanding of the brain and the nature of consciousness. Classifying psychedelic drugs: 1,2 The drugs that are often described as the ‘classical’ psychedelics include LSD-25 (Lysergic Diethylamide), Mescaline (3,4,5- trimethoxyphenylathylamine), Psilocybin (4-hydroxy-N,N-dimethyltryptamine) and DMT (dimethyltryptamine). -
Soma and Haoma: Ayahuasca Analogues from the Late Bronze Age
ORIGINAL ARTICLE Journal of Psychedelic Studies 3(2), pp. 104–116 (2019) DOI: 10.1556/2054.2019.013 First published online July 25, 2019 Soma and Haoma: Ayahuasca analogues from the Late Bronze Age MATTHEW CLARK* School of Oriental and African Studies (SOAS), Department of Languages, Cultures and Linguistics, University of London, London, UK (Received: October 19, 2018; accepted: March 14, 2019) In this article, the origins of the cult of the ritual drink known as soma/haoma are explored. Various shortcomings of the main botanical candidates that have so far been proposed for this so-called “nectar of immortality” are assessed. Attention is brought to a variety of plants identified as soma/haoma in ancient Asian literature. Some of these plants are included in complex formulas and are sources of dimethyl tryptamine, monoamine oxidase inhibitors, and other psychedelic substances. It is suggested that through trial and error the same kinds of formulas that are used to make ayahuasca in South America were developed in antiquity in Central Asia and that the knowledge of the psychoactive properties of certain plants spreads through migrants from Central Asia to Persia and India. This article summarizes the main arguments for the botanical identity of soma/haoma, which is presented in my book, The Tawny One: Soma, Haoma and Ayahuasca (Muswell Hill Press, London/New York). However, in this article, all the topics dealt with in that publication, such as the possible ingredients of the potion used in Greek mystery rites, an extensive discussion of cannabis, or criteria that we might use to demarcate non-ordinary states of consciousness, have not been elaborated. -
Evaluation of the Evidence for the Trauma and Fantasy Models of Dissociation
Psychological Bulletin © 2012 American Psychological Association 2012, Vol. 138, No. 3, 550–588 0033-2909/12/$12.00 DOI: 10.1037/a0027447 Evaluation of the Evidence for the Trauma and Fantasy Models of Dissociation Constance J. Dalenberg Bethany L. Brand California School of Professional Psychology at Alliant Towson University International University, San Diego David H. Gleaves and Martin J. Dorahy Richard J. Loewenstein University of Canterbury Sheppard Pratt Health System, Baltimore, Maryland, and University of Maryland School of Medicine, Baltimore Etzel Carden˜a Paul A. Frewen Lund University University of Western Ontario Eve B. Carlson David Spiegel National Center for Posttraumatic Stress Disorder, Menlo Park, Stanford University School of Medicine and Veterans Administration Palo Alto Health Care System, Palo Alto, California The relationship between a reported history of trauma and dissociative symptoms has been explained in 2 conflicting ways. Pathological dissociation has been conceptualized as a response to antecedent traumatic stress and/or severe psychological adversity. Others have proposed that dissociation makes individuals prone to fantasy, thereby engendering confabulated memories of trauma. We examine data related to a series of 8 contrasting predictions based on the trauma model and the fantasy model of dissociation. In keeping with the trauma model, the relationship between trauma and dissociation was consistent and moderate in strength, and remained significant when objective measures of trauma were used. Dissociation was temporally related to trauma and trauma treatment, and was predictive of trauma history when fantasy proneness was controlled. Dissociation was not reliably associated with suggestibility, nor was there evidence for the fantasy model prediction of greater inaccuracy of recovered memory. -
Psilocybin Mushrooms Fact Sheet
Psilocybin Mushrooms Fact Sheet January 2017 What are psilocybin, or “magic,” mushrooms? For the next two decades thousands of doses of psilocybin were administered in clinical experiments. Psilocybin is the main ingredient found in several types Psychiatrists, scientists and mental health of psychoactive mushrooms, making it perhaps the professionals considered psychedelics like psilocybin i best-known naturally-occurring psychedelic drug. to be promising treatments as an aid to therapy for a Although psilocybin is considered active at doses broad range of psychiatric diagnoses, including around 3-4 mg, a common dose used in clinical alcoholism, schizophrenia, autism spectrum disorders, ii,iii,iv research settings ranges from 14-30 mg. Its obsessive-compulsive disorder, and depression.xiii effects on the brain are attributed to its active Many more people were also introduced to psilocybin metabolite, psilocin. Psilocybin is most commonly mushrooms and other psychedelics as part of various found in wild or homegrown mushrooms and sold religious or spiritual practices, for mental and either fresh or dried. The most popular species of emotional exploration, or to enhance wellness and psilocybin mushrooms is Psilocybe cubensis, which is creativity.xiv usually taken orally either by eating dried caps and stems or steeped in hot water and drunk as a tea, with Despite this long history and ongoing research into its v a common dose around 1-2.5 grams. therapeutic and medical benefits,xv since 1970 psilocybin and psilocin have been listed in Schedule I of the Controlled Substances Act, the most heavily Scientists and mental health professionals criminalized category for drugs considered to have a consider psychedelics like psilocybin to be “high potential for abuse” and no currently accepted promising treatments as an aid to therapy for a medical use – though when it comes to psilocybin broad range of psychiatric diagnoses.